243 filings
Page 4 of 13
S-3/A
5wzqg ymc5
17 Oct 23
Shelf registration (amended)
5:00pm
CORRESP
aeeevi 5css9
17 Oct 23
Correspondence with SEC
12:00am
UPLOAD
3855kv13jsdblt1g
13 Oct 23
Letter from SEC
12:00am
S-3
z8vwt 7avobf020qbe
10 Oct 23
Shelf registration
5:00pm
8-K
3sgnf922a2
27 Sep 23
Material Modifications to Rights of Security Holders
4:30pm
D
6hiqybjusjq5olv
20 Sep 23
Indefinite amount in equity / options / securities to be acquired, sold $1.60 mm, 2 investors
5:32pm
8-K
qc94zk16g3dyk71h
15 Sep 23
Entry into a Material Definitive Agreement
8:45am
8-K
qed3 f5wki180
11 Aug 23
Departure of Directors or Certain Officers
8:15am
8-K
hr7opjp
27 Jul 23
Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives
4:01pm
8-K
psn0h nepa
17 Jul 23
Other Events
5:10pm
8-K
oyt mfwqfsfvhxygl
11 Jul 23
Entry into a Material Definitive Agreement
4:05pm
424B4
j850bw8v
7 Jul 23
Prospectus supplement with pricing info
4:30pm
8-K
zvpwslb
6 Jul 23
Allarity Therapeutics, Inc. Announces Pricing of $11 Million Public Offering
6:05am
EFFECT
egshr5k0s
6 Jul 23
Notice of effectiveness
12:15am
8-K
ewztv
5 Jul 23
Other Events
4:31pm
8-K
xmn4tt6qvz83s
30 Jun 23
Entry into a Material Definitive Agreement
4:05pm
CORRESP
57sygq1d
30 Jun 23
Correspondence with SEC
12:00am
CORRESP
1j9y8fz
30 Jun 23
Correspondence with SEC
12:00am